These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 9167938)
1. Unidentified antioxidant defences of human plasma in immobilized patients: a possible relation to basic metabolic rate. Aejmelaeus R; Ketelä TM; Pirttilä T; Hervonen A; Alho H Free Radic Res; 1997 Apr; 26(4):335-41. PubMed ID: 9167938 [TBL] [Abstract][Full Text] [Related]
2. Age-related changes in the peroxyl radical scavenging capacity of human plasma. Aejmelaeus RT; Holm P; Kaukinen U; Metsä-Ketelä TJ; Laippala P; Hervonen AL; Alho HE Free Radic Biol Med; 1997; 23(1):69-75. PubMed ID: 9165298 [TBL] [Abstract][Full Text] [Related]
3. Is there an unidentified defence mechanism against infection in human plasma? Aejmelaeus R; Metsä-Ketelä T; Laippala P; Alho H FEBS Lett; 1996 Apr; 384(2):128-30. PubMed ID: 8612807 [TBL] [Abstract][Full Text] [Related]
4. The total peroxyl radical-trapping ability of plasma and cerebrospinal fluid in normal and preeclamptic parturients. Uotila JT; Kirkkola AL; Rorarius M; Tuimala RJ; Metsä-Ketelä T Free Radic Biol Med; 1994 May; 16(5):581-90. PubMed ID: 8026801 [TBL] [Abstract][Full Text] [Related]
5. The effect of ascorbate and ubiquinone supplementation on plasma and CSF total antioxidant capacity. Lönnrot K; Metsä-Ketelä T; Molnár G; Ahonen JP; Latvala M; Peltola J; Pietilä T; Alho H Free Radic Biol Med; 1996; 21(2):211-7. PubMed ID: 8818636 [TBL] [Abstract][Full Text] [Related]
7. The association between the total antioxidant potential of plasma and the presence of coronary heart disease and renal dysfunction in patients with NIDDM. Leinonen J; Rantalaiho V; Lehtimäki T; Koivula T; Wirta O; Pasternack A; Alho H Free Radic Res; 1998 Oct; 29(4):273-81. PubMed ID: 9860042 [TBL] [Abstract][Full Text] [Related]
8. Antioxidant defences are reduced during the oral glucose tolerance test in normal and non-insulin-dependent diabetic subjects. Ceriello A; Bortolotti N; Crescentini A; Motz E; Lizzio S; Russo A; Ezsol Z; Tonutti L; Taboga C Eur J Clin Invest; 1998 Apr; 28(4):329-33. PubMed ID: 9615913 [TBL] [Abstract][Full Text] [Related]
9. Postnatal changes in plasma chain-breaking antioxidants in healthy preterm infants fed formula and/or human milk. van Zoeren-Grobben D; Lindeman JH; Houdkamp E; Brand R; Schrijver J; Berger HM Am J Clin Nutr; 1994 Dec; 60(6):900-6. PubMed ID: 7985631 [TBL] [Abstract][Full Text] [Related]
10. Reduced free-radical-trapping capacity and altered plasma antioxidant status in cystic fibrosis. Langley SC; Brown RK; Kelly FJ Pediatr Res; 1993 Mar; 33(3):247-50. PubMed ID: 8460060 [TBL] [Abstract][Full Text] [Related]
11. The relative contributions of vitamin E, urate, ascorbate and proteins to the total peroxyl radical-trapping antioxidant activity of human blood plasma. Wayner DD; Burton GW; Ingold KU; Barclay LR; Locke SJ Biochim Biophys Acta; 1987 Jun; 924(3):408-19. PubMed ID: 3593759 [TBL] [Abstract][Full Text] [Related]
12. Effects of anthracyclin-based chemotherapy on total plasma antioxidant capacity in small cell lung cancer patients. Erhola M; Kellokumpu-Lehtinen P; Metsä-Ketelä T; Alanko K; Nieminen MM Free Radic Biol Med; 1996; 21(3):383-90. PubMed ID: 8855450 [TBL] [Abstract][Full Text] [Related]
13. Effects of surgical removal of lung cancer on total plasma antioxidant capacity in lung cancer patients. Erhola M; Nieminen MM; Kellokumpu-Lehtinen P; Huusari H; Alanko K; Metsä-Ketelä T; Alho H J Exp Clin Cancer Res; 1998 Jun; 17(2):219-25. PubMed ID: 9700584 [TBL] [Abstract][Full Text] [Related]
14. Human plasma antioxidant capacity during radiotherapy for lung cancer: a clinical study. Erhola M; Nieminen MM; Ojala A; Metsä-Ketelä T; Kellokumpu-Lehtinen P; Alho H J Exp Clin Cancer Res; 1998 Sep; 17(3):325-30. PubMed ID: 9894770 [TBL] [Abstract][Full Text] [Related]
15. Critical evaluation of plasma and LDL oxidant-trapping potential in hemodialysis patients. Nguyen-Khoa T; Massy ZA; Witko-Sarsat V; Thévenin M; Touam M; Lambrey G; Lacour B; Drüeke TB; Descamps-Latscha B Kidney Int; 1999 Aug; 56(2):747-53. PubMed ID: 10432417 [TBL] [Abstract][Full Text] [Related]
16. Plasma chain-breaking antioxidants in preterm infants with good and poor short-term outcome. Luukkainen P; Aejmelaeus R; Alho H; Metsä-Ketelä T; Ikonen SR; Salo MK Free Radic Res; 1999 Mar; 30(3):189-97. PubMed ID: 10711789 [TBL] [Abstract][Full Text] [Related]
17. Plasma antioxidants and longevity: a study on healthy centenarians. Mecocci P; Polidori MC; Troiano L; Cherubini A; Cecchetti R; Pini G; Straatman M; Monti D; Stahl W; Sies H; Franceschi C; Senin U Free Radic Biol Med; 2000 Apr; 28(8):1243-8. PubMed ID: 10889454 [TBL] [Abstract][Full Text] [Related]
18. Effect of an exchange transfusion on plasma antioxidants in the newborn. Lindeman JH; Lentjes EG; Houdkamp E; van Zoeren-Grobben D; Schrijver J; Berger HM Pediatrics; 1992 Aug; 90(2 Pt 1):200-3. PubMed ID: 1641283 [TBL] [Abstract][Full Text] [Related]